WHG
ABBV icon

Westwood Holdings Group’s AbbVie ABBV Stock Holding History

Westwood Holdings Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Buy
8,635
+318
+4% +$70.5K 0.01% 323
2025
Q4 		$1.9M Sell
8,317
-130
-2% -$29.6K 0.02% 342
2025
Q3 		$1.96M Sell
8,447
-134
-2% -$27.3K 0.01% 345
2025
Q2 		$1.59M Sell
8,581
-224
-3% -$41.6K 0.01% 348
2025
Q1 		$1.84M Sell
8,805
-2,575
-23% -$501K 0.01% 327
2024
Q4 		$2.02M Sell
11,380
-92
-0.8% -$16.9K 0.02% 325
2024
Q3 		$2.27M Buy
11,472
+92
+0.8% +$17.2K 0.01% 327
2024
Q2 		$1.95M Buy
11,380
+130
+1% +$21.5K 0.01% 319
2024
Q1 		$2.05M Buy
11,250
+959
+9% +$165K 0.02% 312
2023
Q4 		$1.59M Sell
10,291
-64
-0.6% -$9.33K 0.01% 335
2023
Q3 		$1.54M Sell
10,355
-165
-2% -$24.2K 0.01% 317
2023
Q2 		$1.42M Buy
10,520
+98
+0.9% +$14.4K 0.01% 326
2023
Q1 		$1.66M Buy
10,422
+1,664
+19% +$254K 0.01% 314
2022
Q4 		$1.42M Buy
8,758
+113
+1% +$17.3K 0.01% 325
2022
Q3 		$1.16M Sell
8,645
-28
-0.3% -$4.02K 0.01% 305
2022
Q2 		$1.33M Sell
8,673
-379
-4% -$57.9K 0.01% 320
2022
Q1 		$1.47M Sell
9,052
-655
-7% -$95.1K 0.01% 332
2021
Q4 		$1.31M Sell
9,707
-219,669
-96% -$25.9M 0.01% 331
2021
Q3 		$24.7M Sell
229,376
-25,750
-10% -$2.94M 0.27% 125
2021
Q2 		$28.7M Buy
255,126
+244,858
+2,385% +$27.6M 0.29% 106
2021
Q1 		$1.11M Sell
10,268
-670
-6% -$71.7K 0.01% 339
2020
Q4 		$1.17M Buy
10,938
+500
+5% +$48K 0.01% 329
2020
Q3 		$915K Sell
10,438
-780
-7% -$73.4K 0.01% 322
2020
Q2 		$1.1M Hold
11,218
– – 0.01% 321
2020
Q1 		$854K Sell
11,218
-140
-1% -$11.9K 0.01% 322
2019
Q4 		$1M Buy
11,358
+1,765
+18% +$147K 0.01% 342
2019
Q3 		$726K Hold
9,593
– – 0.01% 359
2019
Q2 		$698K Buy
9,593
+2,200
+30% +$173K 0.01% 375
2019
Q1 		$596K Sell
7,393
-1,363
-16% -$112K 0.01% 342
2018
Q4 		$807K Sell
8,756
-500
-5% -$44K 0.01% 309
2018
Q3 		$876K Sell
9,256
-826
-8% -$78.3K 0.01% 322
2018
Q2 		$934K Buy
10,082
+400
+4% +$39.1K 0.01% 332
2018
Q1 		$917K Sell
9,682
-530
-5% -$58.2K 0.01% 328
2017
Q4 		$987K Buy
10,212
+376
+4% +$35.4K 0.01% 319
2017
Q3 		$874K Sell
9,836
-2,169
-18% -$165K 0.01% 319
2017
Q2 		$870K Buy
12,005
+1,755
+17% +$118K 0.01% 323
2017
Q1 		$668K Sell
10,250
-85,145
-89% -$5.35M 0.01% 328
2016
Q4 		$5.97M Sell
95,395
-949
-1% -$57.9K 0.05% 240
2016
Q3 		$6.08M Sell
96,344
-1,570
-2% -$102K 0.05% 228
2016
Q2 		$6.06M Buy
97,914
+1,085
+1% +$66.1K 0.05% 223
2016
Q1 		$5.53M Sell
96,829
-8,458
-8% -$471K 0.05% 229
2015
Q4 		$6.24M Buy
105,287
+31,005
+42% +$1.79M 0.05% 213
2015
Q3 		$4.04M Buy
74,282
+25,355
+52% +$1.65M 0.04% 253
2015
Q2 		$3.29M Buy
48,927
+39,227
+404% +$2.56M 0.02% 265
2015
Q1 		$568K Hold
9,700
– – ﹤0.01% 311
2014
Q4 		$635K Hold
9,700
– – ﹤0.01% 310
2014
Q3 		$560K Hold
9,700
– – ﹤0.01% 307
2014
Q2 		$547K Hold
9,700
– – ﹤0.01% 300
2014
Q1 		$499K Hold
9,700
– – ﹤0.01% 299
2013
Q4 		$512K Hold
9,700
– – ﹤0.01% 294
2013
Q3 		$434K Hold
9,700
– – ﹤0.01% 315
2013
Q2 		$401K Buy
+9,700
New +$424K ﹤0.01% 321

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westwood Holdings Group's ABBV Position: Q1 2026 in Review

Westwood Holdings Group increased its AbbVie (ABBV) stake by 3.8% in Q1 2026, buying an estimated $70.5K and bringing the position to 8,635 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #323.

Westwood Holdings Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.7M in Q2 2021. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Westwood Holdings Group held 8,635 shares of AbbVie worth $1.88M as of Q1 2026.
  • Westwood Holdings Group bought 318 AbbVie shares in Q1 2026, an estimated $70.5K.
  • AbbVie made up 0.01% of Westwood Holdings Group's portfolio in Q1 2026, its #323 holding.
  • Westwood Holdings Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Westwood Holdings Group's AbbVie position peaked at $28.7M in Q2 2021.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Westwood Holdings Group's 13F filing for Q1 2026, filed 15 May 2026.